The role of dopamine oxidation in mitochondrial dysfunction: implications for Parkinson's disease.
about
The role of oxidative stress in Parkinson's diseaseRedox Imbalance and Viral Infections in Neurodegenerative DiseasesCatecholamine autotoxicity. Implications for pharmacology and therapeutics of Parkinson disease and related disordersCellular models to investigate biochemical pathways in Parkinson's diseaseMitochondria-Targeted Protective Compounds in Parkinson's and Alzheimer's DiseasesNovel (Hetero)arylalkenyl propargylamine compounds are protective in toxin-induced models of Parkinson's diseaseSigma-1 receptor deficiency reduces MPTP-induced parkinsonism and death of dopaminergic neuronsInsulin resistance in brain alters dopamine turnover and causes behavioral disorders.Parkin-mediated selective mitochondrial autophagy, mitophagy: Parkin purges damaged organelles from the vital mitochondrial network.Impaired metabolic reactivity to oxidative stress in early psychosis patientsIncrease in blood-brain barrier permeability, oxidative stress, and activated microglia in a rat model of blast-induced traumatic brain injury.Human SOD2 modification by dopamine quinones affects enzymatic activity by promoting its aggregation: possible implications for Parkinson's diseaseThe parkinsonian mimetic, MPP+, specifically impairs mitochondrial transport in dopamine axonsAssociations of Ozone and PM2.5 Concentrations With Parkinson's Disease Among Participants in the Agricultural Health Study.WldS but not Nmnat1 protects dopaminergic neurites from MPP+ neurotoxicity.Axon degeneration in Parkinson's diseaseDeficient vesicular storage: A common theme in catecholaminergic neurodegeneration.Thiol-redox signaling, dopaminergic cell death, and Parkinson's diseaseNeurotransmitter CART as a New Therapeutic Candidate for Parkinson's DiseaseThe role of thyroid hormones as inductors of oxidative stress and neurodegeneration.Mic60/mitofilin overexpression alters mitochondrial dynamics and attenuates vulnerability of dopaminergic cells to dopamine and rotenone.Mitochondria-targeted antioxidants for treatment of Parkinson's disease: preclinical and clinical outcomes.Defective autophagy in Parkinson's disease: role of oxidative stress.Long-term effects of ionising radiation on the brain: cause for concern?Metallobiology of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity.Dopamine imbalance in Huntington's disease: a mechanism for the lack of behavioral flexibility.Nrf2/ARE-mediated antioxidant actions of pro-electrophilic drugs.Interrelation of oxidative stress and inflammation in neurodegenerative disease: role of TNF.Presence of Androgen Receptor Variant in Neuronal Lipid Rafts.Shikonin protects dopaminergic cell line PC12 against 6-hydroxydopamine-mediated neurotoxicity via both glutathione-dependent and independent pathways and by inhibiting apoptosis.Proteinopathy, oxidative stress and mitochondrial dysfunction: cross talk in Alzheimer's disease and Parkinson's diseaseElevated cerebrospinal fluid ratios of cysteinyl-dopamine/3,4-dihydroxyphenylacetic acid in parkinsonian synucleinopathies.Glutathione Peroxidase 4 is associated with Neuromelanin in Substantia Nigra and Dystrophic Axons in Putamen of Parkinson's brain.Dopamine induces the accumulation of insoluble prion protein and affects autophagic flux.Alpha-Synuclein Fibrils Interact with Dopamine Reducing its Cytotoxicity on PC12 Cells.Bioactivity of Olive Oil Phenols in Neuroprotection.Evidence for cross-hemispheric preconditioning in experimental Parkinson's disease.Glia Maturation Factor Dependent Inhibition of Mitochondrial PGC-1α Triggers Oxidative Stress-Mediated Apoptosis in N27 Rat Dopaminergic Neuronal Cells.LRRK2 G2019S-induced mitochondrial DNA damage is LRRK2 kinase dependent and inhibition restores mtDNA integrity in Parkinson's disease.PCB95 and PCB153 change dopamine levels and turn-over in PC12 cells.
P2860
Q24307946-FCB3DE90-B78F-40B4-B9B1-55A1C455782BQ26750630-86621386-CBDC-4CD3-B019-3B2D28C7CD72Q26826093-10F9B506-C090-48AD-B0B1-B6791E04B8D9Q26829742-55AB7F2F-ABBA-4619-BE5A-783E97808F6CQ26859141-C62A5773-626B-4D9E-ACCD-DB31E0A16CBAQ27301283-29EB4F1F-908B-46E1-94B8-83AE757A32F1Q27330088-284BE30F-993C-4B1D-B254-C9BAD3E89E4DQ30631520-00E0F74C-5539-4223-AE27-D170F575FD89Q33746288-B69457E0-BC80-4104-A519-87670CC396D7Q34048645-6557ADA2-FD5C-4377-8320-C4FDC8B003DDQ34249725-A07E3DC4-CA46-4CB4-85AC-A2A0F537306CQ34313803-2E15B7F0-DC2C-4448-B1A7-2C13107EFC2CQ35119950-C2F9A168-EF37-411C-8A4A-A6A3A7C51E81Q35597397-2C6F53D6-F8B9-45E6-8203-3D01C974B70FQ35878214-20B2A1FC-5542-4AF5-854B-2C49E07CF5A4Q35923102-E5291801-A3F7-4C6A-BA82-BE783E373C8FQ36011221-51C392B3-67B9-4308-A8D0-AEBC06DCBFE1Q36326535-871C2954-376F-4C20-AC1A-14E84B631F4EQ36720922-B581AAE8-AC32-4195-909B-369122625C14Q37412519-2EC7986E-145A-4F0A-86BD-C5361C7DDF32Q37631968-F898949F-7700-41DE-800E-886285F6D4C3Q37653023-7A3312BE-8833-47B9-9094-339C19E892E4Q38035191-5E3386AC-9748-4D86-ADF3-E4B9085A63BAQ38055706-BDE4358E-7B84-4B4C-A97A-51EC4B2C5E97Q38074340-682729F6-B2DD-4AD0-AA7D-7F6FF8ADF507Q38121068-4B13A12A-7BFA-448B-BA5A-25BC0BB75A0AQ38124678-4711C563-21A0-4711-AC4D-C87F693E2CB7Q38401306-553C658F-1BAA-42CF-8B2C-0533EC83E7E7Q38693739-5D48EA7E-0BCB-4DAA-B918-AA694C6A77FAQ39157576-73A182A6-AB0E-4247-80EE-0830C750AA04Q39205712-DD2D3C49-283D-497A-84AB-10C19485F0B8Q41655727-FD87779D-E675-4596-B538-86C89A6ECD03Q41981348-2C216A81-5485-4EF2-B216-61012F62AD19Q41982345-9A3E350E-6E88-4ABD-B891-73A01379657BQ46687858-3C50266F-C2DE-44C8-AE5E-75090B08924FQ47099956-5735FDED-2653-4291-9181-B8C8FBE54506Q47441179-F38BBE53-EF4F-487E-ADF2-00DFCCF2BAE5Q47641870-53BFC26E-2BD0-4D72-BB75-1D244FA67ED3Q48560989-89A94F5E-24D0-40CD-93E3-0BA0EA0D7490Q49887516-F1C098AC-1ED2-44F9-8E71-60C92974D094
P2860
The role of dopamine oxidation in mitochondrial dysfunction: implications for Parkinson's disease.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The role of dopamine oxidation ...... tions for Parkinson's disease.
@en
The role of dopamine oxidation ...... tions for Parkinson's disease.
@nl
type
label
The role of dopamine oxidation ...... tions for Parkinson's disease.
@en
The role of dopamine oxidation ...... tions for Parkinson's disease.
@nl
prefLabel
The role of dopamine oxidation ...... tions for Parkinson's disease.
@en
The role of dopamine oxidation ...... tions for Parkinson's disease.
@nl
P921
P1476
The role of dopamine oxidation ...... tions for Parkinson's disease.
@en
P2093
Teresa G Hastings
P2860
P2888
P304
P356
10.1007/S10863-009-9257-Z
P577
2009-12-01T00:00:00Z